OSRH (OSR Holdings, Inc.) Stock Market Reviews

crown

search

Read and share opinions on OSRH (OSR Holdings, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

OSRH

OSR Holdings, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion
Nov 14, 2025
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study
Nov 6, 2025
Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target
Oct 20, 2025
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care
Oct 14, 2025
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity
Sep 9, 2025
OSR Holdings Second Quarter 2025 Earnings: EPS: US$0.02 (vs US$1.83 loss in 2Q 2024)
Aug 20, 2025
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025
Aug 1, 2025
OSR Holdings Provides Transparency Update on Equity Financing Instruments
Jul 31, 2025
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure
Jul 30, 2025
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology
Jul 24, 2025
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company
Jul 15, 2025
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics
May 2, 2025
Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology
Apr 9, 2025
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies
Apr 3, 2025
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer
Mar 25, 2025

Reviews